Bridgebio Pharma Inc (BBIO)

R&D Expense Growth

18.01%

Quarterly · Period ending:

BBIO logo

BBIO R&D Expense Growth

Latest reported18.01%
BBIO Quarterly R&D Growth (QoQ) (0.00% → 18.01%)
High-resolution chart · PNG

BBIO r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Bridgebio Pharma Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
18.0138%
-10.8197%
25.804%
1.4771%
-0.1795%
-14.514%
8.2246%
5.0124%
-18.6399%
8.2518%
4.0676%
16.4186%
15.7515%
2.1551%
-1.7393%
-14.6577%
0.6976%
-11.9075%
17.1564%
2.2999%
-16.8074%
35.9139%
-2.038%
6.2958%
26.93%
18.6831%
3.9925%
5.6315%
16.6722%
-12.3999%
64.3829%
30.37%
-29.3784%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.